Gateway Investment Advisers LLC Decreases Position in Avantor, Inc. (NYSE:AVTR)

Gateway Investment Advisers LLC trimmed its holdings in shares of Avantor, Inc. (NYSE:AVTR) by 45.0% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 111,662 shares of the company’s stock after selling 91,360 shares during the period. Gateway Investment Advisers LLC’s holdings in Avantor were worth $2,353,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. UMB Bank n.a. purchased a new position in Avantor during the 3rd quarter valued at about $49,000. Nisa Investment Advisors LLC boosted its holdings in Avantor by 69.6% in the third quarter. Nisa Investment Advisors LLC now owns 2,035 shares of the company’s stock valued at $53,000 after acquiring an additional 835 shares in the last quarter. GAMMA Investing LLC increased its position in Avantor by 89.9% during the 3rd quarter. GAMMA Investing LLC now owns 2,715 shares of the company’s stock valued at $70,000 after purchasing an additional 1,285 shares during the period. Livforsakringsbolaget Skandia Omsesidigt raised its holdings in Avantor by 278.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,031 shares of the company’s stock worth $130,000 after purchasing an additional 3,700 shares in the last quarter. Finally, Quarry LP lifted its position in shares of Avantor by 4,489.1% in the 2nd quarter. Quarry LP now owns 6,333 shares of the company’s stock worth $134,000 after purchasing an additional 6,195 shares during the period. 95.08% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms recently issued reports on AVTR. Barclays decreased their price target on shares of Avantor from $28.00 to $25.00 and set an “overweight” rating for the company in a research note on Friday, October 25th. Robert W. Baird lowered their target price on Avantor from $27.00 to $26.00 and set an “outperform” rating for the company in a research note on Monday, October 28th. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $34.00 price target on shares of Avantor in a research note on Thursday, September 26th. UBS Group reissued a “neutral” rating and set a $25.00 price objective (down previously from $29.00) on shares of Avantor in a research report on Friday. Finally, Wells Fargo & Company reduced their target price on shares of Avantor from $30.00 to $28.00 and set an “overweight” rating on the stock in a research report on Monday, October 28th. Three analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. According to data from MarketBeat, Avantor has an average rating of “Moderate Buy” and a consensus price target of $27.38.

Avantor Stock Down 1.9 %

Shares of Avantor stock opened at $22.14 on Friday. The company has a 50-day simple moving average of $21.46 and a two-hundred day simple moving average of $23.34. The stock has a market capitalization of $15.07 billion, a PE ratio of 48.13, a price-to-earnings-growth ratio of 3.42 and a beta of 1.28. Avantor, Inc. has a 52-week low of $19.59 and a 52-week high of $28.00. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.06 and a current ratio of 1.54.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.